Searchable abstracts of presentations at key conferences in endocrinology

ea0022s24.3 | Diagnosis and treatment of endocrine malignancies | ECE2010

Parathyroid carcinoma

Szende Bela

Proliferative processes of the parathyroid gland cause hyperparathyrosis (HP), Primary HP-s (carcinoma, adenoma, hyperplasia) are characterised by absence of feedback to seCa level. Out of estimated 20–40/100 000 cases of hypercalcemia (HC), mainly due to HP, only 25% becomes detected. The relative incidence of parythyroid carcinoma (PCc) among causes of HC is 1–2%, but the highest seCa and parathormone (PH) levels are caused by PCc. Clinical diagnosis of PCc is base...